Maria Cherska: Composite Metabolic Markers Could Refine Stroke Prevention
Maria Cherska, The Head of Cardiology Department at The State Institution V.P. Komisarenko Institute of Endocrinology and Metabolism, shared a post on LinkedIn about a recent article by Yueyi He et al, published in Lipids in Health and Desease, adding:
“Can metabolic health markers improve stroke prediction?
Stroke prevention starts long before the first neurological symptom.
A newly published cohort study in Lipids in Health and Disease evaluated whether combining a novel metabolic index—CHG (cholesterol–HDL–glucose index)—with obesity measures could improve the prediction of future stroke compared with the widely used TyG index.
Key findings:
- 7,905 adults aged greater than or equal to 45 years were followed, with 739 incident stroke events recorded.
- Among seven CHG-derived obesity indices, CHG-CVAI and CHG-WC demonstrated the strongest predictive performance and outperformed TyG-derived indicators.
- Individuals in the highest quartile of CHG-CVAI had more than a 2-fold higher risk of stroke after adjustment for major confounders, and sustained high levels over time were associated with even greater risk.
These findings reinforce an important concept in preventive cardiology: integrating biochemical and anthropometric markers may identify high-risk individuals earlier than traditional metabolic indices alone.
As cardiovascular prevention evolves, composite metabolic markers could become valuable tools for more personalized risk stratification and earlier intervention.
Congratulations to the authors on this important contribution to the field.”
Title: Predictive value of cholesterol, high-density lipoprotein, and glucose index-obesity-derived index for stroke: a cohort study
Authors: Yueyi He, Chang Liu, Puhua Cao, Bixing Yan, Ling Zhao, Xiaolong Xie, Wei Fang
Other posts featuring Maria Cherska on Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI